EXAS gapped up and sold off trying a short 106/100 put spread 6 points wide
Price was $2.28 max gain is $1.86/ $4.14
Max loss is $1.70 taking the loss in the the Oct 14-20 if it goes sour.
I'm trying a new strategy,
2 week trade. Sept 27 exp. Cost $1.89
108/103 Put Spread
Profit target is $217.70, Cost to cover is $122.85
2.31% of Capital. Good position.
Only downside is it could bounce as its not a bounce off the trend-line so its more risky in that manner however it could continue lower.
Because of the recent strong growth, the price looks like to wait to break the new high.
But, if we see the longtime moving, EXAS tends to growth below a resistance line.
Even in its best time 2017, the upper resistance worked well.
At that period, the lower resistance line seems to be 50MA.
However, even if we neglect the last large breaking, the lower resistance...
Playing Trading Simulator Game:
On 17JAN18, had about 10 times the average trading volume!
Where will the price go from here?
I think it usually goes up.
EXAS, place a buy limit order with a other cancels other order for the target/stop, still learning.
Buy order: 44.00
Target: 50.00
Stop: 43.00
Time Frame: Feb 20th
If your in EXAS, I would go ahead and get out. It powered out of a nice rounding bottom to blast towards an unsustainable rate of ascent. On the daily chart it looks like it formed an eve and adam double top. Its formation is however, a little messy. I would cut gains and hope for a re-entry bounce at support. If you want to stay and wait, i would suggest raising...
Exact Sciences shares are trading firmly above the uptrend line, which suggests that higher prices are likely to continue. This bullish view is further supported by the golden cross that was generated in July 2016.
A golden cross is a bullish indicator that is produced when the faster 50-day moving average (highlighted in blue) crosses above the slower 200-day...
The trend line acts as a line in the sand; trading above it means that a bull marker is still in development, and that, therefore, higher prices are expected to follow. Trading below this trend line would serve to suggest that a bullish move toward higher prices has concluded, and that a larger correction is set to ensue.
Exact Sciences shares are trading firmly...
After the breakout of the long term downward trendline Exas is making higher highs and higher lows, with a possible uptrend continuation. Every strong breakout of the rising trendline can change the trend with a deeper correction.
Exact Sciences Corporation is a molecular diagnostics company. The Company focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer. Its Cologuard test is a stool-based deoxyribonucleic acid (sDNA) screening test, which utilizes a multi-target approach to detect deoxyribonucleic acid (DNA) and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Cologuard test is intended for the qualitative detection of colorectal neoplasia associated DNA markers and for the presence of occult hemoglobin in human stool. It focuses on the development of additional tests for other types of cancer. It is developing a blood-based biomarker test to aid in the early detection of lung cancer in individuals with lung nodules discovered through a computerized tomography (CT) or other scan.
This website uses cookies to ensure you get the best experience on our website. To learn more about cookies, including how to control cookies, please read our Cookies Policy.
EXAS
